| Authors: |
Dummer R; aDepartment of Dermatology, Skin Cancer Unit, University Hospital Zurich, Zurich, Switzerland., Sandhu S; bSir Peter MacCallum Cancer Department of Oncology, University of Melbourne, Melbourne, Australia., Miller WH Jr; cLady Davis Institute and Segal Cancer Centre, Jewish General Hospital, Departments of Medicine and Oncology, McGill University, Montreal, Canada., Butler MO; dPrincess Margaret Cancer Centre, University Health Network, Departments of Medicine and Immunology, University of Toronto, Toronto, Canada., Taylor MH; eEarle A. Chiles Research Institute, Providence Cancer Institute, Portland, OR, USA., Heinzerling L; fDepartment of Dermatology and Allergy, University Hospital, Ludwig Maximilian University, Munich, Germany., Blank CU; gDepartment of Medical Oncology, Netherlands Cancer Institute, Amsterdam, the Netherlands., Couselo EM; hDepartment of Medical Oncology, Melanoma and Other Skin Cancers Unit, Vall d'Hebron Hospital and Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain., Burris HA 3rd; iSarah Cannon Research Institute, Nashville, TN, USA., Postow MA; jDepartment of Medicine, Memorial Sloan Kettering Cancer Center and Weill Cornell Medical College, New York, NY, USA., Chmielowski B; kJonsson Comprehensive Cancer Center, Division of Hematology-Oncology, Department of Medicine, University of California Los Angeles, Los Angeles, CA, USA., Middleton MR; lNIHR Oxford Biomedical Research Centre, Oxford University Hospitals NHS Foundation Trust, John Radcliffe Hospital, Oxford, UK; Department of Oncology, University of Oxford, Oxford, UK; Early Phase Clinical Trials Unit, Cancer & Haematology Centre, Churchill Hospital, Oxford, UK., Berking C; mDepartment of Dermatology, Uniklinikum Erlangen, CCC Erlangen - EMN, Friedrich-Alexander-University Erlangen-Nürnberg (FAU), Erlangen, Germany., Hassel JC; nHeidelberg University, Medical Faculty Heidelberg, Department of Dermatology and National Center for Tumor Diseases (NCT), NCT Heidelberg, a partnership between DKFZ and University Hospital Heidelberg, Heidelberg, Germany., Gesierich AH; oDepartment of Dermatology, Venerology and Allergology, University Hospital Würzburg, Würzburg, Germany., Mauch C; pDepartment of Dermatology and Venereology, Faculty of Medicine and University Hospital of Cologne, Cologne, Germany., Kleha JF; qPfizer, New York, NY, USA., Polli A; rPfizer, Milan, Italy., Harney AS; sPfizer Boulder Research Unit, Boulder, CO, USA., di Pietro A; rPfizer, Milan, Italy., Ascierto PA; tMelanoma, Cancer Immunotherapy and Innovative Therapies Unit, Istituto Nazionale Tumori IRCCS Fondazione Pascale, Napoli, Italy. |
